Skip to main content
PMC home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1978 Dec 9;119(11):1315-6, 1319.

When is a clinical event an adverse drug reaction?

M R Achong
PMCID: PMC1818576  PMID: 737607

Full text

PDF
1319

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bravo J. F., Jacobson M. P., Mertens B. F. Fatty liver and pleural effusion with ibuprofen therapy. Ann Intern Med. 1977 Aug;87(2):200–201. doi: 10.7326/0003-4819-87-2-200. [DOI] [PubMed] [Google Scholar]
  2. Brogden R. N., Pinder R. M., Sawyer P. R., Speight T. M., Avery G. S. Naproxen: a review of its pharmacological properties and therapeutic efficacy and use. Drugs. 1975;9(5):326–363. doi: 10.2165/00003495-197509050-00002. [DOI] [PubMed] [Google Scholar]
  3. Cuthbert M. F. Adverse reactions to non-steroidal antirheumatic drugs. Curr Med Res Opin. 1974;2(9):600–610. doi: 10.1185/03007997409115265. [DOI] [PubMed] [Google Scholar]
  4. Decker J. L., Steinberg A. D., Gershwin M. E., Seaman W. E., Klippel J. H., Plotz P. H., Paget S. A. Systemic lupus erythematosus. Contrasts and comparisons. Ann Intern Med. 1975 Mar;82(3):391–404. doi: 10.7326/0003-4819-82-3-391. [DOI] [PubMed] [Google Scholar]
  5. Fauci A. S., Wolff S. M. Granulomatous hepatitis. Prog Liver Dis. 1976;5:609–621. [PubMed] [Google Scholar]
  6. Feinstein A. R. Clinical biostatistics. 28. The biostatistical problems of pharmaceutical surveillance. Clin Pharmacol Ther. 1974 Jul;16(1):110–123. doi: 10.1002/cpt1974161part1110. [DOI] [PubMed] [Google Scholar]
  7. Karch F. E., Lasagna L. Toward the operational identification of adverse drug reactions. Clin Pharmacol Ther. 1977 Mar;21(3):247–254. doi: 10.1002/cpt1977213247. [DOI] [PubMed] [Google Scholar]
  8. Karch F. E., Smith C. L., Kerzner B., Mazzullo J. M., Weintraub M., Lasagna L. Adverse drug reactions-a matter of opinion. Clin Pharmacol Ther. 1976 May;19(5 Pt 1):489–492. doi: 10.1002/cpt1976195part1489. [DOI] [PubMed] [Google Scholar]
  9. Koch-Weser J., Sellers E. M., Zacest R. The ambiguity of adverse drug reactions. Eur J Clin Pharmacol. 1977 Jan 3;11(2):75–78. doi: 10.1007/BF00562895. [DOI] [PubMed] [Google Scholar]
  10. Law I. P., Knight H. Jaundice associated with naproxen. N Engl J Med. 1976 Nov 18;295(21):1201–1201. doi: 10.1056/NEJM197611182952119. [DOI] [PubMed] [Google Scholar]
  11. Lee S. L., CHase P. H. Drug-induced systemic lupus erythematosus: a critical review. Semin Arthritis Rheum. 1975 Aug;5(1):83–103. doi: 10.1016/0049-0172(75)90024-4. [DOI] [PubMed] [Google Scholar]
  12. Mandell B., Shen H. S., Hepburn B. Letter: Fever from ibuprofen in a patient with lupus erythematosus. Ann Intern Med. 1976 Aug;85(2):209–210. doi: 10.7326/0003-4819-85-2-209. [DOI] [PubMed] [Google Scholar]
  13. Mitchell D. N., Scadding J. G. Sarcoidosis. Am Rev Respir Dis. 1974 Dec;110(6):774–802. doi: 10.1164/arrd.1974.110.6P1.774. [DOI] [PubMed] [Google Scholar]
  14. Sonnenblick M., Abraham A. S. Ibuprofen hypersensitivity in systemic lupus erythematosus. Br Med J. 1978 Mar 11;1(6113):619–620. doi: 10.1136/bmj.1.6113.619. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES